Filter Results:
(258)
Show Results For
- All HBS Web
(120,184)
- Faculty Publications (258)
Show Results For
- All HBS Web
(120,184)
- Faculty Publications (258)
- August 2011 (Revised September 2011)
- Background Note
U.S. Universities and Technology Transfer
By: Richard G. Hamermesh, Josh Lerner and Phillip Andrews
Technology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the... View Details
Keywords: Higher Education; Information Technology; Laws and Statutes; Education Industry; Technology Industry; United States
Hamermesh, Richard G., Josh Lerner, and Phillip Andrews. "U.S. Universities and Technology Transfer." Harvard Business School Background Note 812-016, August 2011. (Revised September 2011.)
- June 2011
- Teaching Note
Whose Money Is It Anyway? (TN) (A), (B), and (C)
By: Richard G. Hamermesh, V.G. Narayanan and Rachel Gordon
Teaching Note for 810-008, 810-013, and 810-031. View Details
Keywords: Health Industry
- June 2011
- Teaching Note
Novasys Medical (TN)
Teaching Note for 810027. View Details
- June 2011 (Revised October 2013)
- Case
Gene Patents (A)
By: Richard Hamermesh, David Kiron and Phillip Andrews
In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues... View Details
Keywords: Courts and Trials; Patents; Genetics; Judgments; Science-Based Business; Biotechnology Industry; United States
Hamermesh, Richard, David Kiron, and Phillip Andrews. "Gene Patents (A)." Harvard Business School Case 811-089, June 2011. (Revised October 2013.)
- March 2011 (Revised March 2011)
- Case
Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform
Per the Patient Protection and Affordable Care Act (PPACA), which President Obama signed in 2010, states would be required to create state-wide health insurance marketplaces - the Health Benefit Exchanges (HBEs) - in which individuals and small employers could choose... View Details
Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Emerging Markets; Risk and Uncertainty; Health Industry; Insurance Industry; New Jersey
Oberholzer-Gee, Felix, Raffaella Sadun, and Richard G. Hamermesh. "Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform." Harvard Business School Case 711-403, March 2011. (Revised March 2011.)
- March 2011
- Teaching Note
PrimedicProviding Primary Care in Mexico (TN)
Teaching Note for 811040. View Details
- November 2010 (Revised January 2011)
- Case
Computerized Provider Order Entry at Emory Healthcare
By: Richard G. Hamermesh, F. Warren McFarlan, Mark Keil, Andrew Katz, Michael Morgan and David LaBorde
The Computerized Provider Order Entry at Emory Healthcare case presents one hospital system's efforts to implement computerized provider order entry (CPOE) across all of its hospitals and the challenges they faced in doing so. Issues such as standardization of care,... View Details
Keywords: Health Care and Treatment; Information Management; Management Systems; Standards; Service Delivery; Business Processes; Organizational Change and Adaptation; Projects; Information Technology; Applications and Software; Health Industry
Hamermesh, Richard G., F. Warren McFarlan, Mark Keil, Andrew Katz, Michael Morgan, and David LaBorde. "Computerized Provider Order Entry at Emory Healthcare." Harvard Business School Case 311-061, November 2010. (Revised January 2011.)
- October 2010 (Revised July 2011)
- Case
PrimedicProviding Primary Care in Mexico
By: Richard G. Hamermesh, Regina Garcia-Cuellar and Lauren Sarah Margulies
Primedic is a Mexican start-up that aims to deliver affordable primary and preventative healthcare to those at the base of the economic pyramid. The company is about to exhaust its first round of venture capital funding and the business model has yet to gain traction.... View Details
Keywords: Business Model; Business Startups; Developing Countries and Economies; Social Entrepreneurship; Venture Capital; Health Care and Treatment; Social Enterprise; Health Industry; Mexico
Hamermesh, Richard G., Regina Garcia-Cuellar, and Lauren Sarah Margulies. "PrimedicProviding Primary Care in Mexico." Harvard Business School Case 811-040, October 2010. (Revised July 2011.)
- October 2010 (Revised November 2010)
- Background Note
Plavix: Drugs in the Age of Personalized Medicine
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details
Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry
Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "Plavix: Drugs in the Age of Personalized Medicine." Harvard Business School Background Note 811-001, October 2010. (Revised November 2010.)
- October 2010 (Revised June 2015)
- Teaching Note
MINTing Innovation at NewYork-Presbyterian (A) and (B)
By: Richard G. Hamermesh and David Kiron
Teaching Note for 810004 and 815113. View Details
- March 2010 (Revised June 2010)
- Case
Whose Money Is It Anyway? (A)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The Brigham and Women's Physician's Organization (BWPO) and its corporate parent disagree over who has jurisdiction over significant legacy funds. Are they controlled by the BWPO or do they belong to BWPO's corporate parent? The BWPO and its corporate parent must... View Details
Keywords: Accounting; Investment Funds; Governance Controls; Agreements and Arrangements; Boundaries; Health Industry
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (A)." Harvard Business School Case 810-008, March 2010. (Revised June 2010.)
- March 2010
- Supplement
Whose Money Is It Anyway? (B)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The case describes the various reactions of doctors and administrators to the solutions they developed. View Details
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (B)." Harvard Business School Supplement 810-013, March 2010.
- March 2010
- Supplement
Whose Money Is It Anyway? (C)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The case describes how the Brigham and Women's Physicians Organization and its corporate parent resolved the issue of how the disputed funds would be distributed and used. View Details
Keywords: Corporate Governance; Business Subsidiaries; Organizational Design; Conflict and Resolution; Resource Allocation; Health Industry
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (C)." Harvard Business School Supplement 810-031, March 2010.
- February 2010
- Case
Shurgard Self-Storage: Expansion to Europe (Abridged)
Shurgard, a U.S.-based firm that rents storage facilities to consumers and small businesses, is considering financing options for rapid expansion of its European operations. Five years after entering Europe, Shurgard Europe has opened 17 facilities in Belgium, France,... View Details
Keywords: Business Model; Business Growth and Maturation; Multinational Firms and Management; Logistics; Corporate Entrepreneurship; Trade; Equity; Corporate Finance; United States; Europe
Hamermesh, Richard G. "Shurgard Self-Storage: Expansion to Europe (Abridged)." Harvard Business School Case 810-102, February 2010.
- January 2010
- Teaching Note
State of Emergency at Mercy Hospital and The Jenner Situation (TN)
Teaching Note for [809070] and [409048]. View Details
- November 2009
- Case
The Explosion of Genetic Testing: Opportunities and Challenges
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
This case study invites the reader to consider genetic testing in several different lights. First, can the business of genetic testing be considered a disruptive innovation to the current drug therapy model as defined by Harvard Business School Professor Clay... View Details
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- September 2009 (Revised August 2012)
- Case
Novasys Medical
By: Richard G. Hamermesh and Lauren Barley
Novasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Health Disorders; Product Development; Business and Government Relations; Medical Devices and Supplies Industry; United States
Hamermesh, Richard G., and Lauren Barley. "Novasys Medical." Harvard Business School Case 810-027, September 2009. (Revised August 2012.)
- August 2009 (Revised June 2015)
- Case
MINTing Innovation at NewYork-Presbyterian (A)
By: Richard G. Hamermesh and David Kiron
Several top surgeons at NewYork-Presbyterian Hospital (NYP) are receiving financial and administrative support to advance their surgical device inventions through the earliest stages of commercialization. View Details
Keywords: Health Care; Innovation & Entrepreneurship; Hospital; Entrepreneurship; Financing and Loans; Investment; Health Care and Treatment; Innovation and Invention; Intellectual Property; Commercialization; Health Industry; Medical Devices and Supplies Industry; New York (state, US)
Hamermesh, Richard G., and David Kiron. "MINTing Innovation at NewYork-Presbyterian (A)." Harvard Business School Case 810-004, August 2009. (Revised June 2015.)
- May 2009 (Revised August 2010)
- Case
The Jenner Situation
By: Richard G. Hamermesh, Andy Whittemore and Eliot Sherman
Dr. Bill Lemont is the new chief medical officer of a large academic medical center. During his first week on the job he has become aware of the abusive behavior and temper outbursts of a prominent orthopedic surgeon. How Dr. Lemont handles the situation will be... View Details
Keywords: Interpersonal Communication; Employee Relationship Management; Managerial Roles; Behavior; Conflict Management; Health Industry
Hamermesh, Richard G., Andy Whittemore, and Eliot Sherman. "The Jenner Situation." Harvard Business School Case 809-070, May 2009. (Revised August 2010.)